Overview

Drug Use Investigation for TYKERB Tablet (All Case Investigation)

Status:
Completed
Trial end date:
2017-03-13
Target enrollment:
Participant gender:
Summary
Data on the safety and efficacy of TYKERB shall be collected from the patients in order to grasp the actual conditions of post-marketing use and assess background information on the patients.
Details
Lead Sponsor:
Novartis
Treatments:
Lapatinib